Close

Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession

Go back to Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
(NASDAQ: LUMO) Delayed: 2.80 --0 (-0%)
Previous Close $2.80    52 Week High
Open $2.90    52 Week Low
Day High $2.93    P/E N/A 
Day Low $2.72    EPS
Volume 46,348